Europe Endometriosis Market Size, Share & Industry Trends Analysis Report By Type, By Treatment (Oral Contraceptives, Gonadotropin-releasing hormone (GnRH) medicines, and Others), By Distribution Channel, By Country and Growth Forecast, 2022

List of Tables

The Europe Endometriosis Market would witness market growth of 11.4% CAGR during the forecast period (2022-2028).

A laparoscopy is typically used to confirm endometriosis. This little procedure entails making a tiny incision beneath the belly button in the abdominal wall while under anesthesia (umbilicus). To view inside, a laparoscope, a thin telescope-like equipment, is put through the skin. The doctor can see areas of endometriosis.

The main goals of treatment are to reduce the discomfort and heavy periods associated with endometriosis, as well as to increase fertility if it has been impacted. Endometriosis can be treated in a number of ways. If the patient's fertility is unaffected by the endometriosis and the symptoms are moderate, therapy may not be desired. About 3 out of 10 times, endometriosis resolves on its own, and symptoms disappear. If symptoms persist or worsen, the patient can always alter their mind and choose endometriosis treatment.

In order to better the lives of patients and boost the economy, the UK government has allocated £790 million to encourage innovations in novel therapies, diagnostics, and medical technology. To enhance the delivery of health and care in a safe manner and better address health issues like cancer treatment and drug error reduction, £25 million will be allocated for patient safety research. Significant funding pledges to advance research in all regions of the nation level the playing field for innovation and address health disparities. Following significant investment to promote ground-breaking experimental medicine research and expand the UK's response to patient safety problems, patients throughout the nation are expected to benefit from novel new medicines and improved health and care service delivery. This will spur market expansion in the Europe region.

The Germany market dominated the Europe Endometriosis Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $146.2 million by 2028. The UK market is anticipated to grow at a CAGR of 10.5% during (2022 - 2028). Additionally, The France market would exhibit a CAGR of 12.2% during (2022 - 2028).

Based on Type, the market is segmented into Superficial Peritoneal Lesion, Endometriomas, and Others. Based on Treatment, the market is segmented into Oral Contraceptives, Gonadotropin-releasing hormone (GnRH) medicines, and Others. Based on Distribution Channel, the market is segmented into Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Teva Pharmaceuticals Industries Ltd., Sun Pharmaceutical Industries Ltd., Sanofi S.A., AbbVie, Inc., AstraZeneca PLC, Pfizer, Inc., Merck & Co., Inc., GlaxoSmithKline PLC, Abbott Laboratories, and Consilient Health Limited.

Scope of the Study

Market Segments covered in the Report:

By Type

Superficial Peritoneal Lesion
Endometriomas
Others

By Treatment

Oral Contraceptives
Gonadotropin-releasing hormone (GnRH) medicines
Others

By Distribution Channel

Hospital Pharmacy
Retail Pharmacy
Online Pharmacy

By Country

Germany
UK
France
Russia
Spain
Italy
Rest of Europe

Companies Profiled

Teva Pharmaceuticals Industries Ltd.
Sun Pharmaceutical Industries Ltd.
Sanofi S.A.
AbbVie, Inc.
AstraZeneca PLC
Pfizer, Inc.
Merck & Co., Inc.
GlaxoSmithKline PLC
Abbott Laboratories
Consilient Health Limited

Unique Offerings from KBV Research

Exhaustive coverage
Highest number of market tables and figures
Subscription based model available
Guaranteed best price
Assured post sales research support with 10% customization free

Chapter 1. Market Scope & Methodology

1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
- 1.4.1 Europe Endometriosis Market, by Type
- 1.4.2 Europe Endometriosis Market, by Treatment
- 1.4.3 Europe Endometriosis Market, by Distribution Channel
- 1.4.4 Europe Endometriosis Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview

2.1 Introduction
- 2.1.1 Overview
  - 2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
- 2.2.1 Market Drivers
- 2.2.2 Market Restraints

Chapter 3. Europe Endometriosis Market by Type

3.1 Europe Superficial Peritoneal Lesion Market by Country
3.2 Europe Endometriomas Market by Country
3.3 Europe Others Market by Country

Chapter 4. Europe Endometriosis Market by Treatment

4.1 Europe Oral Contraceptives Market by Country
4.2 Europe Gonadotropin-releasing hormone (GnRH) medicines Market by Country
4.3 Europe Others Market by Country

Chapter 5. Europe Endometriosis Market by Distribution Channel

5.1 Europe Hospital Pharmacy Market by Country
5.2 Europe Retail Pharmacy Market by Country
5.3 Europe Online Pharmacy Market by Country

Chapter 6. Europe Endometriosis Market by Country

6.1 Germany Endometriosis Market
- 6.1.1 Germany Endometriosis Market by Type
- 6.1.2 Germany Endometriosis Market by Treatment
- 6.1.3 Germany Endometriosis Market by Distribution Channel
6.2 UK Endometriosis Market
- 6.2.1 UK Endometriosis Market by Type
- 6.2.2 UK Endometriosis Market by Treatment
- 6.2.3 UK Endometriosis Market by Distribution Channel
6.3 France Endometriosis Market
- 6.3.1 France Endometriosis Market by Type
- 6.3.2 France Endometriosis Market by Treatment
- 6.3.3 France Endometriosis Market by Distribution Channel
6.4 Russia Endometriosis Market
- 6.4.1 Russia Endometriosis Market by Type
- 6.4.2 Russia Endometriosis Market by Treatment
- 6.4.3 Russia Endometriosis Market by Distribution Channel
6.5 Spain Endometriosis Market
- 6.5.1 Spain Endometriosis Market by Type
- 6.5.2 Spain Endometriosis Market by Treatment
- 6.5.3 Spain Endometriosis Market by Distribution Channel
6.6 Italy Endometriosis Market
- 6.6.1 Italy Endometriosis Market by Type
- 6.6.2 Italy Endometriosis Market by Treatment
- 6.6.3 Italy Endometriosis Market by Distribution Channel
6.7 Rest of Europe Endometriosis Market
- 6.7.1 Rest of Europe Endometriosis Market by Type
- 6.7.2 Rest of Europe Endometriosis Market by Treatment
- 6.7.3 Rest of Europe Endometriosis Market by Distribution Channel

Chapter 7. Company Profiles

7.1 Abbott Laboratories
- 7.1.1 Company Overview
- 7.1.2 Financial Analysis
- 7.1.3 Segmental and Regional Analysis
- 7.1.4 Research & Development Expense
- 7.1.5 SWOT Analysis
7.2 Teva Pharmaceutical Industries Ltd.
- 7.2.1 Company Overview
- 7.2.2 Financial Analysis
- 7.2.3 Regional Analysis
- 7.2.4 Research & Development Expenses
- 7.2.5 Recent strategies and developments:
  - 7.2.5.1 Product Launches and Product Expansions:
7.3 Sun Pharmaceutical Industries Ltd.
- 7.3.1 Company Overview
- 7.3.2 Financial Analysis
- 7.3.3 Regional Analysis
- 7.3.4 Research & Development Expenses
7.4 Sanofi S.A.
- 7.4.1 Company Overview
- 7.4.2 Financial Analysis
- 7.4.3 Segmental and Regional Analysis
- 7.4.4 Research & Development Expense
7.5 AbbVie, Inc.
- 7.5.1 Company Overview
- 7.5.2 Financial Analysis
- 7.5.3 Regional Analysis
- 7.5.4 Research & Development Expense
- 7.5.5 Recent strategies and developments:
  - 7.5.5.1 Trials and Approvals:
7.6 AstraZeneca PLC
- 7.6.1 Company Overview
- 7.6.2 Financial Analysis
- 7.6.3 Regional Analysis
- 7.6.4 Research & Development Expenses
7.7 Pfizer, Inc.
- 7.7.1 Company Overview
- 7.7.2 Financial Analysis
- 7.7.3 Regional & Segmental Analysis
- 7.7.4 Research & Development Expense
- 7.7.5 Recent strategies and developments:
  - 7.7.5.1 Partnerships, Collaborations, and Agreements:
  - 7.7.5.2 Trials and Approvals:
7.8 Merck & Co., Inc.
- 7.8.1 Company Overview
- 7.8.2 Financial Analysis
- 7.8.3 Segmental and Regional Analysis
- 7.8.4 Research & Development Expenses
- 7.8.5 Recent strategies and developments:
  - 7.8.5.1 Trials and Approvals:
7.9 GlaxoSmithKline PLC
- 7.9.1 Company Overview
- 7.9.2 Financial Analysis
- 7.9.3 Segmental and Regional Analysis
- 7.9.4 Research & Development Expense
- 7.9.5 Recent strategies and developments:
  - 7.9.5.1 Trials and Approvals:
  - 7.9.5.2 Acquisition and Mergers:
7.10. Consilient Health Limited
- 7.10.1 Company Overview

LIST OF TABLES

TABLE 1 Europe Endometriosis Market, 2018 - 2021, USD Million
TABLE 2 Europe Endometriosis Market, 2022 - 2028, USD Million
TABLE 3 Europe Endometriosis Market by Type, 2018 - 2021, USD Million
TABLE 4 Europe Endometriosis Market by Type, 2022 - 2028, USD Million
TABLE 5 Europe Superficial Peritoneal Lesion Market by Country, 2018 - 2021, USD Million
TABLE 6 Europe Superficial Peritoneal Lesion Market by Country, 2022 - 2028, USD Million
TABLE 7 Europe Endometriomas Market by Country, 2018 - 2021, USD Million
TABLE 8 Europe Endometriomas Market by Country, 2022 - 2028, USD Million
TABLE 9 Europe Others Market by Country, 2018 - 2021, USD Million
TABLE 10 Europe Others Market by Country, 2022 - 2028, USD Million
TABLE 11 Europe Endometriosis Market by Treatment, 2018 - 2021, USD Million
TABLE 12 Europe Endometriosis Market by Treatment, 2022 - 2028, USD Million
TABLE 13 Europe Oral Contraceptives Market by Country, 2018 - 2021, USD Million
TABLE 14 Europe Oral Contraceptives Market by Country, 2022 - 2028, USD Million
TABLE 15 Europe Gonadotropin-releasing hormone (GnRH) medicines Market by Country, 2018 - 2021, USD Million
TABLE 16 Europe Gonadotropin-releasing hormone (GnRH) medicines Market by Country, 2022 - 2028, USD Million
TABLE 17 Europe Others Market by Country, 2018 - 2021, USD Million
TABLE 18 Europe Others Market by Country, 2022 - 2028, USD Million
TABLE 19 Europe Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 20 Europe Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 21 Europe Hospital Pharmacy Market by Country, 2018 - 2021, USD Million
TABLE 22 Europe Hospital Pharmacy Market by Country, 2022 - 2028, USD Million
TABLE 23 Europe Retail Pharmacy Market by Country, 2018 - 2021, USD Million
TABLE 24 Europe Retail Pharmacy Market by Country, 2022 - 2028, USD Million
TABLE 25 Europe Online Pharmacy Market by Country, 2018 - 2021, USD Million
TABLE 26 Europe Online Pharmacy Market by Country, 2022 - 2028, USD Million
TABLE 27 Europe Endometriosis Market by Country, 2018 - 2021, USD Million
TABLE 28 Europe Endometriosis Market by Country, 2022 - 2028, USD Million
TABLE 29 Germany Endometriosis Market, 2018 - 2021, USD Million
TABLE 30 Germany Endometriosis Market, 2022 - 2028, USD Million
TABLE 31 Germany Endometriosis Market by Type, 2018 - 2021, USD Million
TABLE 32 Germany Endometriosis Market by Type, 2022 - 2028, USD Million
TABLE 33 Germany Endometriosis Market by Treatment, 2018 - 2021, USD Million
TABLE 34 Germany Endometriosis Market by Treatment, 2022 - 2028, USD Million
TABLE 35 Germany Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 36 Germany Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 37 UK Endometriosis Market, 2018 - 2021, USD Million
TABLE 38 UK Endometriosis Market, 2022 - 2028, USD Million
TABLE 39 UK Endometriosis Market by Type, 2018 - 2021, USD Million
TABLE 40 UK Endometriosis Market by Type, 2022 - 2028, USD Million
TABLE 41 UK Endometriosis Market by Treatment, 2018 - 2021, USD Million
TABLE 42 UK Endometriosis Market by Treatment, 2022 - 2028, USD Million
TABLE 43 UK Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 44 UK Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 45 France Endometriosis Market, 2018 - 2021, USD Million
TABLE 46 France Endometriosis Market, 2022 - 2028, USD Million
TABLE 47 France Endometriosis Market by Type, 2018 - 2021, USD Million
TABLE 48 France Endometriosis Market by Type, 2022 - 2028, USD Million
TABLE 49 France Endometriosis Market by Treatment, 2018 - 2021, USD Million
TABLE 50 France Endometriosis Market by Treatment, 2022 - 2028, USD Million
TABLE 51 France Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 52 France Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 53 Russia Endometriosis Market, 2018 - 2021, USD Million
TABLE 54 Russia Endometriosis Market, 2022 - 2028, USD Million
TABLE 55 Russia Endometriosis Market by Type, 2018 - 2021, USD Million
TABLE 56 Russia Endometriosis Market by Type, 2022 - 2028, USD Million
TABLE 57 Russia Endometriosis Market by Treatment, 2018 - 2021, USD Million
TABLE 58 Russia Endometriosis Market by Treatment, 2022 - 2028, USD Million
TABLE 59 Russia Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 60 Russia Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 61 Spain Endometriosis Market, 2018 - 2021, USD Million
TABLE 62 Spain Endometriosis Market, 2022 - 2028, USD Million
TABLE 63 Spain Endometriosis Market by Type, 2018 - 2021, USD Million
TABLE 64 Spain Endometriosis Market by Type, 2022 - 2028, USD Million
TABLE 65 Spain Endometriosis Market by Treatment, 2018 - 2021, USD Million
TABLE 66 Spain Endometriosis Market by Treatment, 2022 - 2028, USD Million
TABLE 67 Spain Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 68 Spain Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 69 Italy Endometriosis Market, 2018 - 2021, USD Million
TABLE 70 Italy Endometriosis Market, 2022 - 2028, USD Million
TABLE 71 Italy Endometriosis Market by Type, 2018 - 2021, USD Million
TABLE 72 Italy Endometriosis Market by Type, 2022 - 2028, USD Million
TABLE 73 Italy Endometriosis Market by Treatment, 2018 - 2021, USD Million
TABLE 74 Italy Endometriosis Market by Treatment, 2022 - 2028, USD Million
TABLE 75 Italy Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 76 Italy Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 77 Rest of Europe Endometriosis Market, 2018 - 2021, USD Million
TABLE 78 Rest of Europe Endometriosis Market, 2022 - 2028, USD Million
TABLE 79 Rest of Europe Endometriosis Market by Type, 2018 - 2021, USD Million
TABLE 80 Rest of Europe Endometriosis Market by Type, 2022 - 2028, USD Million
TABLE 81 Rest of Europe Endometriosis Market by Treatment, 2018 - 2021, USD Million
TABLE 82 Rest of Europe Endometriosis Market by Treatment, 2022 - 2028, USD Million
TABLE 83 Rest of Europe Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 84 Rest of Europe Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 85 Key Information - Abbott Laboratories
TABLE 86 Key Information - Teva Pharmaceuticals Industries Ltd.
TABLE 87 Key Information - Sun Pharmaceutical Industries Ltd.
TABLE 88 Key Information - Sanofi S.A.
TABLE 89 Key information - AbbVie, Inc.
TABLE 90 KEY INFORMATION - AstraZeneca PLC
TABLE 91 Key Information - Pfizer, Inc.
TABLE 92 KEY INFORMATION - Merck & Co., Inc.
TABLE 93 Key Information - GlaxoSmithKline PLC
TABLE 94 Key Information - Consilient Health Limited

List of Figures

FIG 1 Methodology for the research
FIG 2 Swot analysis: Abbott laboratories

Europe Endometriosis Market Size, Share & Industry Trends Analysis Report By Type, By Treatment (Oral Contraceptives, Gonadotropin-releasing hormone (GnRH) medicines, and Others), By Distribution Channel, By Country and Growth Forecast, 2022 - 2028

Description

Table of Contents